SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford GlycoSciences Plc
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (266)12/15/2002 3:16:53 PM
From: scaram(o)uche   of 469
 
Thanks. The more we know about these suckers, the better.

It's obvious that toxicities will be front and center for years, and concerns about such will linger beyond that.

But..... apart from the obvious indications, I believe that NB-GJ could have use for a variety of ACUTE indications.

We could be holding the tail of a tiger. But the tiger is likely to grow old and slow before regulatory agencies are likely to venture too far into its compound.

Heh.... heh..... heh..... "compound". I made a funny.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News